Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7709486 CXCR4 antagonists

Patent 7709486 was granted and assigned to Genzyme on May, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 22 May, 2024

"update inverses"

edited on 22 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11987598 E-selectin antagonist compounds, compositions, and methods of use

0

Edits on 30 Jan, 2024

"update inverses"

edited on 30 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11878026 Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists

0

Edits on 30 Oct, 2023

"Add patent abstract"

edited on 30 Oct, 2023

Edits made to:

Article (+433 characters)

Article

Patent abstract

The present invention is drawn to novel antiviral compounds, pharmaceutical compositions and their use. More specifically this invention is drawn to derivatives of monocyclic polyamines which have activity in standard tests against HIV- or FIV-infected cells as well as other biological activity related to binding of ligands to chemokine receptors that mediate a number of mammalian embryonic developmental processes.

Edits on 11 Oct, 2023

"update inverses"

edited on 11 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11780873 Highly potent multimeric e-selectin antagonists

Edits on 18 Sep, 2023

"Add patent inventor(s)"

edited on 18 Sep, 2023

Edits made to:

Infobox (+6 properties)

Infobox

Patent Inventor Names

David Earl Bogucki0

Dominique Schols0

Eva Maria Boehringer0

Gary J. Bridger0

Renato Tony Skerlj0

Zhongren Wang0

Edits on 2 Aug, 2023

"update inverses"

edited on 2 Aug, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11712446 Methods of mobilizing marrow infiltrating lymphocytes and uses thereof

0

Edits on 26 Jul, 2023

"update inverses"

edited on 26 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11707474 Methods for treating acute myeloid leukemia and related conditions

0

Edits on 20 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 20 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=077094860

Edits on 19 May, 2023

"Remove leading 0 from patent number"

edited on 19 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 07709486 CXCR4 antagonists US Patent 7709486 CXCR4 antagonists

Infobox

Patent Number

077094860

Patent Number

77094860

Edits on 22 Sep, 2022

"Entity importer update"

edited on 22 Sep, 2022

Infobox

Is a

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

077094860

Date of Patent

May 4, 2010

0

Patent Application Number

121820440

Date Filed

July 29, 2008

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=077094860

Patent Primary Examiner

Brenda L Coleman

0

Edits on 18 Jun, 2022

"Entity importer update"

edited on 18 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=07709486

Edits on 4 Dec, 2021

"Created via: Entity Importer"

created this topic on 4 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 07709486 CXCR4 antagonists

Infobox

Is a

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

07709486

Date of patent

May 4, 2010

Patent application number

12182044

Date Filed

July 29, 2008

Patent primary examiner

Brenda L Coleman

Find more entities like US Patent 7709486 CXCR4 antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool